Several lines of evidence that glycosphingolipids (GSLs) may have a role in cell growth regulation have accumulated during the past decade. Most of the many studies reporting involvement of GSLs in cell growth regulation have been based on the changes induced by the addition of exogenous GSL. However, the addition of a GSL to a cell or membrane preparation may produce a misleading effect if the site of action is already occupied by endogenous GSL. Moreover, the production of an effect by exogenous GSL may not signify a physiological role for this lipid since it might simply react with the effector in a nonphysiological way. From these reasons, there was a need to establish the physiological significance of the effect by depleting cellular GSLs specifically. The role of endogenous GSL has been assessed recently because of the availability of D-PDMP and L-PDMP [Reviewed by Radin and Inokuchi (1991) Trends Glycosci. Glycotechnol. 3,200-213] . The former compound inhibits the synthesis of GlcCer by suppressing the activity of UDPglucose: ceramide glucosyl-transferase, resulting in extensive depletion of GSLs derived from GlcCer. Moreover, D-PDMP enhances the cellular levels of sphingosine and N, N'-dimethylsphingosine, potent inhibitors of protein kinase C. In contrast, L-PDMP increases the cellular levels of GSLs, especially LacCer [Inokuchi et al. (1989) J. Cell Physiol. 141, 573-583, and Inokuchi et al. (1990) Cancer Res. 50, 6731-6737] . Using the newly introduced method, the authors reported here have investigated the possible role of endogenous GlcCer or LacCer on cell proliferation.
Shayman et al. employed two independent approaches to examine the role of endogenous GlcCer in mediating the cellular proliferation of MDCK cells(1). First, GSLs of MDCK cells were depleted by D-PDMP. This agent markedly inhibited cell growth and DNA synthesis in a time-and concentration dependent manner. Second, cells were grown in the presence of Exposure of cells to this inhibitor resulted in the time dependent accumulation of GlcCer with a corresponding increase in cellular proliferation. Under these conditions, the authors measured protein kinase C(PKC) activity. PKC activity increased in the presence of conduritol B epoxide and decreased in the presence of D-PDMP in a concentrationdependent manner, implicating the level of GlcCer or a closely related GSL, such as LacCer, in the control of PKC activity. The inhibition of cell growth by D-PDMP might be due to the elevation of endogenous sphingosine. However, there is no direct evidence how GlcCer stimulates PKC activity.
Chatterjee investigated the role of LacCer on smooth muscle cell proliferation(2). Exogenous addition of ceramide, GalCer, GlcCer, LacCer, Gb3Cer or Gb4Cer to the cultured rabbit aortic smooth cells resulted in a significant increase of thymidine uptake into the cells, leading to the cell proliferation. The most profound increase occurred in cells incubated with LacCer; this was in the order of 558% compared to control. D-PDMP markedly prevented the cell proliferation as observed in various type of cells treated with this reagent. In contrast, L-PDMP markedly stimulated the thymidine uptake and subsequent cell proliferation. He also found that incubation of increased GalT-2 activity. This is a new mode of action of PDMP against GalT-2 activity. However, it is not clear whether D-and L-PDMP directly affect GalT-2 activity or change the cellular level of the enzyme. The stimulatory effect of L-PDMP on cell growth seems rather specific for aortic smooth muscle cells since L-PDMP, when incubated with B16 melanoma [Inokuchi et al. (1989) J. Cell Physiol.141, 573-583] and Lewis lung carcinoma cells [Inokuchi et al. (1990) Cancer Res. 50, 6731-6737] produced a marked increase in LacCer level yet did not induce proliferation. Chatterjee also showed that when several type of cell lines were incubated with LacCer, they responded different way; LacCer inhibited cell proliferation of aortic endothelial cells and had no effect on pulmonary endothelial. These phenomena can be found in other reports; in one report Had-1, a UDP-galactose transport-defective mutant of mouse mammary tumor cell FM3A, was inhibited cell proliferation by the addition of LacCer in a dose-dependent manner [Taki et al. (1990 ) Cancer Res. 51, 1701 -1707 and in another LacCer was found to stimulate GM03468 human fibroblast cell proliferation [Ogura and Sweely (1991) Glycoconjugate J. 8, 160]. Thus, it seems that LacCer functions as either positive or negative regulator of cell proliferation, depending on cell type. The reasons for discrepancy in these studies are still unknown.
Further investigations to ascertain the role of GlcCer and/or LacCer in relation to PKC or some other novel signal transaction pathway will be facilitated. 
